Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer M Wiggins

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Journal of Investigative Dermatology|May 22, 2022
Cell-Free DNA in Dermatology ResearchJennifer M Wiggins, Saim Ali, David Polsky
The British Journal of Radiology|March 8, 2018
Tumor oxygenation and cancer therapy-then and nowVeronica S Hughes, Jennifer M Wiggins, Dietmar W Siemann
Methods in Molecular Biology (Clifton, N.J.)|September 11, 2019
Validation of Circulating Tumor DNA Assays for Detection of Metastatic MelanomaMahrukh M Syeda, Jennifer M Wiggins, Broderick Corless, et al.
Oncotarget|May 29, 2018
Stromal cells in breast cancer as a potential therapeutic targetSamantha S Dykes, Veronica S Hughes, Jennifer M Wiggins, et al.
Exercise and Sport Sciences Reviews|November 23, 2017
Exercise and the Tumor Microenvironment: Potential Therapeutic ImplicationsJennifer M Wiggins, Alexander B Opoku-Acheampong, Dryden R Baumfalk, et al.
Plos One|June 6, 2015
Tight Chk1 Levels Control Replication Cluster Activation in XenopusMarie Platel, Arach Goldar, Jennifer M Wiggins, et al.
Plos One|May 4, 2019
Reliability of blood lactate as a measure of exercise intensity in different strains of mice during forced treadmill runningSimon Lønbro, Jennifer M Wiggins, Thomas Wittenborn, et al.
The Journal of Investigative Dermatology|April 26, 2022
Associations between TERT Promoter Mutations and Survival in Superficial Spreading and Nodular Melanomas in a Large Prospective Patient CohortGregory A Chang, Eric Robinson, Jennifer M Wiggins, et al.
The Journal of Investigative Dermatology|February 23, 2020
TERT, BRAF, and NRAS Mutational Heterogeneity between Paired Primary and Metastatic Melanoma TumorsGregory A Chang, Jennifer M Wiggins, Broderick C Corless, et al.
The Lancet. Oncology|February 15, 2021
Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation studyMahrukh M Syeda, Jennifer M Wiggins, Broderick C Corless, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Journal of Investigative Dermatology|May 22, 2022
Cell-Free DNA in Dermatology ResearchJennifer M Wiggins, Saim Ali, David Polsky
The British Journal of Radiology|March 8, 2018
Tumor oxygenation and cancer therapy-then and nowVeronica S Hughes, Jennifer M Wiggins, Dietmar W Siemann
Methods in Molecular Biology (Clifton, N.J.)|September 11, 2019
Validation of Circulating Tumor DNA Assays for Detection of Metastatic MelanomaMahrukh M Syeda, Jennifer M Wiggins, Broderick Corless, et al.
Oncotarget|May 29, 2018
Stromal cells in breast cancer as a potential therapeutic targetSamantha S Dykes, Veronica S Hughes, Jennifer M Wiggins, et al.
Exercise and Sport Sciences Reviews|November 23, 2017
Exercise and the Tumor Microenvironment: Potential Therapeutic ImplicationsJennifer M Wiggins, Alexander B Opoku-Acheampong, Dryden R Baumfalk, et al.
Plos One|June 6, 2015
Tight Chk1 Levels Control Replication Cluster Activation in XenopusMarie Platel, Arach Goldar, Jennifer M Wiggins, et al.
Plos One|May 4, 2019
Reliability of blood lactate as a measure of exercise intensity in different strains of mice during forced treadmill runningSimon Lønbro, Jennifer M Wiggins, Thomas Wittenborn, et al.
The Journal of Investigative Dermatology|April 26, 2022
Associations between TERT Promoter Mutations and Survival in Superficial Spreading and Nodular Melanomas in a Large Prospective Patient CohortGregory A Chang, Eric Robinson, Jennifer M Wiggins, et al.
The Journal of Investigative Dermatology|February 23, 2020
TERT, BRAF, and NRAS Mutational Heterogeneity between Paired Primary and Metastatic Melanoma TumorsGregory A Chang, Jennifer M Wiggins, Broderick C Corless, et al.
The Lancet. Oncology|February 15, 2021
Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation studyMahrukh M Syeda, Jennifer M Wiggins, Broderick C Corless, et al.
Pageof 2